It should also be borne in mind that in the case of sepsis, a sharp and progressive increase in the concentration of the biomarkers mentioned (e.g., IL-6) can be observed, whereas in the case of other diseases, for instance ovarian cancer, their concentration is elevated but does not progress significantly over time [60,61]. This evidence concerns the gene IL6 and Sepsis.